| Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer F Schettini, N Chic, F Brasó-Maristany, L Paré, T Pascual, B Conte, ... NPJ breast cancer 7 (1), 1, 2021 | 390 | 2021 |
| High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice D Santini, F Loupakis, B Vincenzi, I Floriani, I Stasi, E Canestrari, E Rulli, ... The oncologist 13 (12), 1270-1275, 2008 | 309 | 2008 |
| Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer G Perrone, PA Ruffini, V Catalano, C Spino, D Santini, P Muretto, C Spoto, ... European journal of cancer 44 (13), 1875-1882, 2008 | 258 | 2008 |
| Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients D Santini, G Schiavon, B Vincenzi, L Gaeta, F Pantano, A Russo, ... PloS one 6 (4), e19234, 2011 | 208 | 2011 |
| Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases D Santini, G Perrone, I Roato, L Godio, F Pantano, D Grasso, A Russo, ... Journal of cellular physiology 226 (3), 780-784, 2011 | 178 | 2011 |
| Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease R Del Vescovo, I Sansoni, R Caviglia, M Ribolsi, G Perrone, E Leoncini, ... Abdominal imaging 33, 417-424, 2008 | 138 | 2008 |
| Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial N Normanno, AM Rachiglio, M Lambiase, E Martinelli, F Fenizia, ... Annals of oncology 26 (8), 1710-1714, 2015 | 137 | 2015 |
| The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients F Pantano, P Berti, FM Guida, G Perrone, B Vincenzi, MMC Amato, ... Journal of cellular and molecular medicine 17 (11), 1415-1421, 2013 | 103 | 2013 |
| High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory … A Ruzzo, F Graziano, B Vincenzi, E Canestrari, G Perrone, N Galluccio, ... The oncologist 17 (6), 823-829, 2012 | 96 | 2012 |
| Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale AC Gardini, L Faloppi, S De Matteis, FG Foschi, N Silvestris, F Tovoli, ... European Journal of Cancer 86, 106-114, 2017 | 94 | 2017 |
| Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD U Vespasiani‐Gentilucci, S Carotti, G Perrone, C Mazzarelli, G Galati, ... Liver international 35 (2), 569-581, 2015 | 93 | 2015 |
| Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy K Kawakami, F Graziano, G Watanabe, A Ruzzo, D Santini, V Catalano, ... Clinical cancer research 11 (10), 3778-3783, 2005 | 91 | 2005 |
| Lipophagy impairment is associated with disease progression in NAFLD S Carotti, K Aquilano, F Zalfa, S Ruggiero, F Valentini, M Zingariello, ... Frontiers in Physiology 11, 850, 2020 | 88 | 2020 |
| COX‐2 expression in DCIS: correlation with VEGF, HER‐2/neu, prognostic molecular markers and clinicopathological features G Perrone, D Santini, B Vincenzi, M Zagami, A La Cesa, A Bianchi, ... Histopathology 46 (5), 561-568, 2005 | 82 | 2005 |
| Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer G Perrone, B Vincenzi, D Santini, A Verzı, G Tonini, A Vetrani, C Rabitti Cancer letters 208 (2), 227-234, 2004 | 81 | 2004 |
| Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer F Suriano, D Santini, G Perrone, M Amato, B Vincenzi, G Tonini, AO Muda, ... Journal of experimental & clinical cancer research 32, 1-7, 2013 | 64 | 2013 |
| Telemedicine during Covid-19 pandemic: Advantage or critical issue? G Perrone, S Zerbo, C Bilotta, G Malta, A Argo Medico-Legal Journal 88 (2), 76-77, 2020 | 61 | 2020 |
| Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade G Perrone, B Vincenzi, M Zagami, D Santini, R Panteri, G Flammia, ... Modern pathology 20 (3), 344-351, 2007 | 61 | 2007 |
| Cell cycle alterations and lung cancer B Vincenzi, G Schiavon, M Silletta, D Santini, GM Perrone, M Di Marino, ... Histology and histopathology, 2006 | 61 | 2006 |
| Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival S Morini, G Perrone, D Borzomati, B Vincenzi, C Rabitti, D Righi, F Castri, ... Pancreas 42 (1), 60-66, 2013 | 60 | 2013 |
